ABMT for AML in CR1: Prognostic Factors (Univariate Analysis)
| . | . | Relapse (SE) . | LFS (SE) . | Survival (SE) . |
|---|---|---|---|---|
| Cytogenetics | Standard | 0.46 (0.02) | 0.48 (0.02) | 0.54 (0.02) |
| Poor | 0.77 (0.02) | 0.21 (0.06) | 0.29 (0.08) | |
| P | .0002 | .002 | .02 | |
| FAB | M3 | 0.35 (0.07) | 0.60 (0.06) | 0.66 (0.06) |
| Other | 0.51 (0.02) | 0.42 (0.02) | 0.48 (0.02) | |
| P | .01 | .004 | .007 | |
| Int CR-BMT | <127 d | 0.53 (0.03) | 0.40 (0.03) | 0.44 (0.03) |
| ≥127 d | 0.46 (0.03) | 0.48 (0.03) | 0.56 (0.03) | |
| P | .04 | .04 | .02 |
| . | . | Relapse (SE) . | LFS (SE) . | Survival (SE) . |
|---|---|---|---|---|
| Cytogenetics | Standard | 0.46 (0.02) | 0.48 (0.02) | 0.54 (0.02) |
| Poor | 0.77 (0.02) | 0.21 (0.06) | 0.29 (0.08) | |
| P | .0002 | .002 | .02 | |
| FAB | M3 | 0.35 (0.07) | 0.60 (0.06) | 0.66 (0.06) |
| Other | 0.51 (0.02) | 0.42 (0.02) | 0.48 (0.02) | |
| P | .01 | .004 | .007 | |
| Int CR-BMT | <127 d | 0.53 (0.03) | 0.40 (0.03) | 0.44 (0.03) |
| ≥127 d | 0.46 (0.03) | 0.48 (0.03) | 0.56 (0.03) | |
| P | .04 | .04 | .02 |
The Kaplan and Meier estimates are those at 3 years after BMT.
Abbreviations: ABMT, autologous bone marrow transplantation; AML, acute myeloblastic leukemia; CR1, first complete remission; SE, standard error of the mean; LFS, leukemia-free survival; FAB, French-American-British classification; Int CR-BMT, time interval from complete remission to bone marrow transplantation.